Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy-Reference-Cited by-同舟云学术

Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy

Published:2012-09-14 Issue:4 Volume:52 Page:824-830
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Hultman Bo,Lind Pehr,Glimelius Bengt,Sundbom Magnus,Nygren Peter,Haglund Ulf,Mahteme Haile

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2012.702925

Reference40 articles.

1. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

2. Peritoneal carcinomatosis from non-gynecologic malignancies

3. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination

4. Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Peritoneal Carcinomatosis Arising From Gastric Cancer

5. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conversion surgery for gastric cancer with PM;Journal of Surgical Oncology;2024-08-19

2. Advances in Gastric Cancer Surgical Management;Hematology/Oncology Clinics of North America;2024-06

3. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases;2024-04-21

4. Gene Expression Profile-Guided Personalized Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Carcinomatosis;World Journal of Oncology;2024-04

5. Hyperthermic intraperitoneal chemotherapy for gastric cancer: a narrative review;Chinese Clinical Oncology;2023-12